About the Role
We are seeking a talented professional to partner with regional access leads and anticipate evidence needs from HTA stakeholders across Europe. This role involves working collaboratively with internal cross-functional teams to gather and synthesize evidence for EU HTA-related projects, including PICO surveys and data consolidation.
Your contributions will support the development of market access strategies and clinical development plans for Takeda’s oncology portfolio, with a focus on the evidence needs of the EU and Canadian HTA/payer stakeholders.
You will co-lead the preparation and submission of European Union Health Technology Assessment (HTA) documents, including Joint Clinical Assessments and Joint Scientific Consultations, ensuring compliance with EU Joint HTA guidelines and processes. In this position, you will promote Takeda’s values and foster collaboration with cross-functional and global/region/LOC partners to enhance awareness and adoption of EU HTA evidence requirements.
How You Will Contribute
- Co-lead the strategy and development of high-quality HTA government submission dossiers for the European Union Joint Clinical Assessments (JCA) and Joint Scientific Consultations (JSC) for new oncology medicines in collaboration with the EUCAN Access Lead.
- Work alongside global and EUCAN PVA leads to ensure timely completion of comprehensive mapping of HTA and payer evidence requirements via PICO simulations for assigned assets, contributing to global development plans, statistical analysis plans, and evidence generation strategies.
- Act as a key member of the Payer Value and Patient Access (PVPA) sub-team, representing the joint EU HTA archetype’s evidence needs in internal regional and global forums, and communicating changes in joint HTA guidelines to inform global brand, PVPA functional plans, and asset clinical development strategies.
- Collaborate with the EUCAN Access Lead to co-lead Joint Scientific Consultations, gather feedback on clinical trial considerations, and inform clinical development and evidence generation strategies.
- Serve as the single point of contact for all JCA and JSC-related evidence topics for assigned priority assets, connecting with relevant internal partners and external stakeholders, and interfacing with the HTA Coordination Group.
- Provide guidance to internal stakeholders regarding the methodological requirements and specifications for the EU HTA Regulation methods and procedures, enhancing existing product area expertise.
- Stay informed about EU HTA guidelines, methods, and processes, and communicate relevant updates to internal stakeholders.
- Develop strategic insights based on trends, relationships, and collaboration among national HTA/payers, regulatory agencies (EMA), and the EU HTA CG to shape EU joint HTA and reimbursement strategies.
Education, Behavioural Competencies, and Skills
Required Qualifications
- Minimum bachelor’s degree; advanced or graduate degree (MSc, PhD, MPH, MPP, MBA) preferred.
- Minimum of 6 years of experience in the biopharmaceuticals industry or healthcare consulting.
- At least 4 years of experience in market access, health economics, pricing, health policy, outcomes research, and/or related consulting roles, showcasing increasing responsibility.
- Strong understanding of the EU payer and HTA environment, including HTA trends, reimbursement guidance, and technical methodologies (e.g., EU HTA, NICE, TLV, G-BA, HAS).
- Demonstrated advanced verbal and written communication, presentation, and influencing skills, with the ability to influence without authority and work effectively with cross-functional teams.
- Proven ability to manage complex projects with multiple stakeholders and perform well under pressure.
- Solid knowledge of drug development processes and familiarity with global pharmaceutical cross-functional teams.
- Ability to navigate ambiguity and complex trade-offs in global discussions, striving for optimal HTA submission deliverables.
- Skill in translating HTA strategies into clear value messages for advocacy and stakeholder engagement, while building strong partnerships across relevant organizations.
- Hands-on experience with health technology assessment tools, value materials, methods, evidence synthesis approaches, and HTA/payer insight elicitation.
Preferred Qualifications
- Advanced or graduate degree (MSc, PhD, MPH, MPP, MBA).
- Degree or diploma in health economics or economic evaluations.
- Previous experience in Oncology.
- Experience in a regional or global role.
- Direct experience leading national HTA submissions or engaging in early scientific advice with HTA or regulatory agencies is a plus.
Travel Requirements
20% domestic and/or international travel required.
Additional Information
- Prior experience in assessing evidence needs for major HTA/payer stakeholders in EU5 and/or Canada.
- Excellent collaboration and communication skills, with a proven track record in matrix environments.
- Experience in managing internal stakeholders with a solutions-oriented mindset.
- Strong understanding of the clinical development process.
Apply online using the form below. Please note that only applications matching the job profile will be considered.